Last reviewed · How we verify
Kiklin capsules
At a glance
| Generic name | Kiklin capsules |
|---|---|
| Also known as | ASP1585, ILY101, AMG223, bixalomer |
| Sponsor | Astellas Pharma Inc |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Post-Marketing Surveillance on Long-Term Drug Use of Kiklin (Bixalomer)® Capsules in Patients With Hyperphosphatemia Receiving Peritoneal Dialysis
- Post-marketing Surveillance of Kiklin Capsules in Hemodialysis Patients
- A Study of ASP1585 to Evaluate the Bioequivalence Between ASP1585 Granules and ASP1585 Capsules (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Kiklin capsules CI brief — competitive landscape report
- Kiklin capsules updates RSS · CI watch RSS
- Astellas Pharma Inc portfolio CI